In December 2021, BMJ appointed Professor of Diabetes and Endocrinology, Professor Wasim Hanif and Global Director of Clinical Services for Aetna International, Dr Hemal Desai, to serve on its Board of Directors.
As non-executive directors (NEDs), they will provide independent advice to the leading global healthcare knowledge provider on business decisions and developments. They bring a wealth of experience to BMJ to support its growth in research and digital health offerings.
The new appointees took up their Board positions on December 1, 2021, replacing Dr Hamish Meldrum and Dr Kiran Patel, who served for nearly 10 years each.
Prof. Wasim Hanif is an eminent authority on diabetes, obesity, and ethnic health. As well as holding several clinical and academic posts, he is Trustee of Diabetes UK and the South Asian Health Foundation (SAHF) and was instrumental in setting up UKADS (the United Kingdom Asian Diabetes Study).
Dr. Hemal Desai is Global Director of Clinical Services for Aetna International, where he leads a global medical team to ensure the highest standards of care for members in areas such as emergency assistance, telemedicine, and primary healthcare.
Click here to read the original press release.
